Live from the NIH registry
Studies recruiting near Asheville right now
Top 25 of 125 recruiting studies, sorted by proximity — each links to its official registry page
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Margaret R Pardee Memorial Hospital — Hendersonville, North Carolina (18.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
ERP to Improve Functioning in Veterans With OCD
Obsessive Compulsive Disorder (OCD), Comorbid Post-Traumatic Stress Disorder and OCD
N/A
Interventional 160 participants sought
Asheville VA Medical Center, Asheville, NC — Asheville, North Carolina (2.1 mi)
· Sponsor: VA Office of Research and Development
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Asheville Neurology Specialists — Asheville, North Carolina (2.1 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Children's Oncology Group
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Phase 3
Interventional 1,000 participants sought
Local Institution - 0352 — Asheville, North Carolina (2.1 mi)
· Sponsor: Bristol-Myers Squibb
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: SWOG Cancer Research Network
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
Coronary Artery Disease, High Risk Percutaneous Coronary Intervention
N/A
Interventional 358 participants sought
Mission Health — Asheville, North Carolina (2.1 mi)
· Sponsor: Supira Medical
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
Metastatic Castration-Resistant Prostate Cancer
Phase 2
Interventional 200 participants sought
Messino Cancer Center — Asheville, North Carolina (2.1 mi)
· Sponsor: Zenith Epigenetics
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Cardiology Associates_Asheville — Asheville, North Carolina (2.1 mi)
· Sponsor: Novo Nordisk A/S
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1051 — Asheville, North Carolina (2.1 mi)
· Sponsor: Immunovant Sciences GmbH
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Focal Seizure, Epilepsy
Phase 3
Interventional 333 participants sought
Asheville Neurology Specialists — Asheville, North Carolina (2.1 mi)
· Sponsor: Rapport Therapeutics Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: SWOG Cancer Research Network
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
AdventHealth Infusion Center Asheville — Asheville, North Carolina (2.1 mi)
· Sponsor: SWOG Cancer Research Network
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Graves Disease
Phase 3
Interventional 300 participants sought
Site-038 — Asheville, North Carolina (2.1 mi)
· Sponsor: Biohaven Therapeutics Ltd.
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Non-small Cell Lung Cancer
Phase 3
Interventional 876 participants sought
Charles George VA Medical Center ( Site 3233) — Asheville, North Carolina (2.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
AdventHealth Infusion Center Asheville — Asheville, North Carolina (2.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
Asthma
N/A
Observational 160 participants sought
Allergy Partners Clinical Research — Asheville, North Carolina (2.1 mi)
· Sponsor: Biometry Inc
A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
Diabetic Macular Edema (DME)
Phase 3
Interventional 514 participants sought
Asheville Eye Associates - Retina Division — Asheville, North Carolina (2.1 mi)
· Sponsor: 4D Molecular Therapeutics
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 1,800 participants sought
89bio Clinical Study Site — Asheville, North Carolina (2.1 mi)
· Sponsor: Hoffmann-La Roche
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Margaret R Pardee Memorial Hospital — Hendersonville, North Carolina (18.2 mi)
· Sponsor: SWOG Cancer Research Network
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Stryker Instruments
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Parkinson's Disease Psychosis
Phase 4
Interventional 358 participants sought
Asheville VA Medical Center, Asheville, NC — Asheville, North Carolina (2.1 mi)
· Sponsor: VA Office of Research and Development
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Parkinson Disease
Phase 2
Interventional 150 participants sought
Asheville Neurology Specialists, P.A. (Site #229) — Asheville, North Carolina (2.1 mi)
· Sponsor: Appello Pharmaceuticals, Inc.
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
Intraabdominal Hypertension, Abdominal Compartment Syndrome
N/A
Observational 2,500 participants sought
Mission Health Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Potrero Medical
Device Global Registry for the IlluminOss Bone Stabilization System
Traumatic Fracture, Pathological Fracture
N/A
Observational 300 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: IlluminOss Medical, Inc.